Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies. The company focuses on protecting patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to reduce contrast injected into patients during standard cardiovascular and peripheral procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.